An Off-the-Shelf Instant Contact Casting Device for the Management of Diabetic Foot Ulcers

Diabetes Care - Tập 30 Số 3 - Trang 586-590 - 2007
Alberto Piaggesi1, Silvia Macchiarini1, Loredana Rizzo1, Francesca Palumbo1, Anna Tedeschi1, Laura Ambrosini Nobili1, Elisa Leporati1, Vincenzo Scirè1, Ilaria Teobaldi1, Stefano Del Prato1
1From the Section of Diabetes and Metabolic Diseases, Department of Endocrinology and Metabolism, University of Pisa and Azienda Ospedaliera Pisana, Pisa, Italy

Tóm tắt

OBJECTIVE—This study was designed to test the safety, effectiveness, and costs of off-loading with a novel, off-the-shelf irremovable device in the management of diabetic foot ulceration (DFU). RESEARCH DESIGN AND METHODS—We prospectively evaluated off-loading of neuropathic plantar ulcers in 40 diabetic outpatients attending our diabetic foot clinic and compared healing rates at the 12-week follow-up, number and severity of adverse events, healing time, costs and applicability of the device, and patients’ satisfaction between those randomly assigned to total contact casting (TCC; group A) or to the Optima Diab walker (group B). Deep or infected ulcers were excluded. RESULTS—No difference between groups A and B was observed in healing rates at 12 weeks (95 vs. 85%), healing time (6.5 ± 4.4 vs. 6.7 ± 3.4 weeks), and number of adverse events (six versus four). Treatment was significantly less expensive in group B, which showed a mean reduction of costs of 78% compared with group A (P < 0.001). Practicability was more favorable in group B, with a reduction of 77 and 58% of the time required for application and removal of the devices, respectively (P < 0.001). Patients’ satisfaction with the treatment was higher in group B (P < 0.01). CONCLUSIONS—The Optima Diab walker is as safe and effective as TCC in the management of DFU, but its lower costs and better applicability may be of help in spreading the practice of off-loading among the centers that manage the diabetic foot.

Từ khóa


Tài liệu tham khảo

Reiber GE, Boyko EJ, Smith DG: Lower extremity foot ulcers and amputations in diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Eds. Washington, DC, National Institutes of Health, 1995, p. 409–428

Pecoraro RE: Chronology and determinants of tissue repair in diabetic lower extremity ulcers. Diabetes 40: 1305–1313, 1991

Centers for Disease Control and Prevention (CDC): Lower extremity disease among persons aged > or =40 years with and without diabetes—United States, 1999–2002. MMWR Morb Mortal Wkly Rep 54:1158–1160, 2005

Mayfield JA, Reiber GE, Sanders LJ, Janise D, Pogach LM: Preventive foot care in people with diabetes. Diabetes Care 21:2161–2177, 1998

Boulton AJ: The diabetic foot: from art to science: the 18th Camillo Golgi lecture. Diabetologia 47:1343–1353, 2004

Litzelman DK, Marriot DJ, Vinicor F: Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 20:1273–1278, 1997

Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 21:1714–1719, 1998

Caravaggi C, De Giglio R, Pritelli C, Sommariva M, Dalla Noce S, Faglia E, Mantero M, Clrici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A: Hyaff 11–based autologous derma and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 26:2853–2859, 2003

Caravaggi C, Faglia E, De Giglio R, Mantero M, Quarantiello A, Sommariva E, Gino M, Pritelli C, Morabito A: Effectiveness and safety of a nonremovable feberglass off-bearing cast versus a therapeuthic shoe in the treatment of neuropathic foot ulcers. Diabetes Care 23:1746–1751, 2000

Armstrong DG, Ngyugen HC, Lavery LA, van Schie CHM, Boulton AJM, Harkless LB: Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 24:1019–1022, 2001

Cavanagh PR, Lipsky BA, Bradbury AW, Botek G: Treatment for diabetic foot ulcers: review. Lancet 336:1725–1735, 2005

Wukich DK, Motko J: Safety of total contact casting in high risk patients with diabetic foot ulcers. Foot Ankle Int 25:556–560, 2004

Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boulton AJM: Technique for fabrication of an “instant total contact cast” for treatment of neuropathic diabeticfoot ulcers. J Am Podistr Asso c 92:405–408, 2002

Katz IA, Harlan A, Miranda-Palma B, Prietoi-Sanchez L, Armstrong DG, Bowker JH, Mizel MS, Boulton AJM: A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 28:555–559, 2005

Young MJ, Breddy JL, Veves A, Boulton AJM: The prediction of diabetic neuropathic foot using vibration perception threshold: a prospective study. Diabetes Care 17:557–560, 1994

Armstrong DG, Lavery LA, Harkless LB: Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855–859, 1999

International Working Group on the Diabetic Foot: International Consensus on the Diabetic Foot. Apelqvist J, Bakker K, Nabuurs-Franssen MH, Schaper NC, Van Houtum WH, Eds. Maastricht, Netherlands, 1999

Petre M, Tokar P, Kostar D, Cavanagh PR: Revisiting the total contact cast: maximizing off-loading by wound isolation. Diabetes Care 28:929–930, 2005

Armstrong DG, Lavery LA, Nixon BP, Boulton AJ: It’s not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 39(Suppl. 2):S92–S99, 2004

Piaggesi A, Viacava P, Rizzo L, Naccarato G, Baccetti F, Romanelli M, Zampa V, Del Prato S: Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effect of pressure relief. Diabetes Care 26:3123–3128, 2003

Armstrong DG, Lavery LA, WU S, Boulton AJM: Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds. Diabetes Care 28:551–554, 2005

Ha Van G, Siney H, Hartmann-Heurtier A, Jaqueminet S, Greau F, Grimaldi A: Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance. Diabetes Care 26:2848–2852, 2003

Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM: Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 26:2595–2597, 2003

Nabuurs-Fransenn M, Sleegers R, Huijberts MSP, Wijnen W, Sanders AP, Walenkamp G, Schaper NC: Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 28:243–247, 2005

Brown D, Wertsch JJ, Harris GF, Klein J, Janisse D: Effect of rocker soles on plantar pressures. Arch Phys Med Rehabil 85:81–86, 2004

Lavery LA, Vela SA, Lavery DC, Quebedeaux TL: Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulceration: a comparison of treatments. Diabetes Care 19:818–821, 1996

Garattini L, Chiaffarino F, Cornago D, Coscelli C, Parazzini F, the Study Group RECORD (Rilevazione Economica dei Costi e Risorse del Diabete): Direct medical costs unequivocally related to diabetes in Italian diabetes centers. Eur J Health Econom 5:15–21, 2004

Ortegon MM, Redekop WK, Niessen LW: Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 27:901–907, 2004

Thông tin
Thông tin xuất bản

Diabetes Care

Tập 30 Số 3

586-590

Thông tin tác giả